(Q28244228)

English

Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients

scientific article (publication date: June 2006)

In more languages

Statements

scholarly article

0 references

Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients (English)

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Chi Yuen Cheung

1

0 references

Robert A M Op den Buijsch

2

0 references

Kim Ming Wong

3

0 references

Hoi Wong Chan

4

0 references

Ka Foon Chau

5

0 references

Chun Sang Li

6

0 references

Kay Tai Leung

7

0 references

Tze Hoi Kwan

8

0 references

Johan E de Vrie

9

0 references

Petal Ahm Wijnen

10

0 references

Marja P van Dieijen-Visser

11

0 references

Otto Bekers

12

0 references

language of work or name

0 references

publication date

June 2006

0 references

Pharmacogenomics

0 references

7

0 references

4

0 references

563-74

0 references

A risk-benefit assessment of tacrolimus in transplantation

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Clinical pharmacokinetics of tacrolimus

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure.

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Evaluation of a limited sampling strategy to estimate area under the curve of tacrolimus in adult renal transplant patients

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients.

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Tacrolimus pharmacokinetics in lung transplantation: new strategies for monitoring

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Genetic variability in CYP3A5 and its possible consequences.

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients.

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Genetic polymorphisms of the human MDR1 drug transporter

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors.

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Genotype relationships in the CYP3A locus in Caucasians

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Genotyping of the triallelic variant G2677T/A in MDR1 using LightCycler with locked-nucleic-acid-modified hybridization probes.

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

C2 (2-h) levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal-transplant patients

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Effective oral administration of tacrolimus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Trough levels of tacrolimus

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.563

21 January 2018

Identifiers

10.2217/14622416.7.4.563

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28244228&oldid=1457642289"